Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Xarelto Review Puts FDA’s Comparative Effectiveness Stance To The Test

Sep 19 2011

• By Sue Sutter

Related Content

ROCKET AF’s Design Causes Headaches For <i>Xarelto</i> Sponsors

Sep 19 2011

<i>Pradaxa</i> Vs. <i>Xarelto</i>: How The Advisory Committees Voted

Sep 19 2011

<i>Xarelto</i> Faces Approval, Labeling Obstacles Even After Cmte. Endorsement

Sep 12 2011

Xarelto's Comparative Efficacy To Warfarin, Pradaxa Will Be Focus At FDA Panel Review

Sep 06 2011

<i>Pradaxa</i> Review Shows FDA Doubts About The Power Of REMS To Change Prescribing Practices

Apr 01 2011

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window